CHINA PHARMA HOLDINGS, INC. Other Comprehensive Income (Loss), Net of Tax
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Other Comprehensive Income (Loss), Net of Tax of -$3.43 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2018-08-14
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for the quarter ending 2018-06-30 was -$3.43M.
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for the quarter ending 2018-03-31 was $1.38M.
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for the quarter ending 2017-12-31 was -$13.96M.
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for the quarter ending 2017-09-30 was -$112.03K.
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for fiscal 2017 was -$15.84M.
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for fiscal 2016 was -$13.73M.
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for fiscal 2015 was -$20.10M.
- CHINA PHARMA HOLDINGS, INC. other comprehensive income (loss), net of tax for fiscal 2014 was -$40.20M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | -$3.43M 10-Q · filed 2018-08-14 | -$2.05M 10-Q · filed 2018-08-14 | -$16.01M derived: sum of 3 quarters · filed 2018-08-14 | -$16.12M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2018-03-31 | $1.38M 10-Q · filed 2018-05-14 | -$12.58M derived: sum of 2 quarters · filed 2018-05-14 | -$12.69M derived: sum of 3 quarters · filed 2018-05-14 | -$13.97M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-12-31 | -$13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$14.07M derived: sum of 2 quarters · filed 2018-04-02 | -$15.35M derived: sum of 3 quarters · filed 2018-08-14 | -$15.84M 10-K · filed 2018-04-02 | ||||
| 2017-09-30 | -$112.03K 10-Q · filed 2017-11-14 | -$1.39M derived: sum of 2 quarters · filed 2018-08-14 | -$1.88M 10-Q · filed 2017-11-14 | -$7.90M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-06-30 | -$1.28M 10-Q · filed 2018-08-14 | -$1.77M 10-Q · filed 2018-08-14 | -$7.79M derived: sum of 3 quarters · filed 2018-08-14 | -$9.82M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | -$487.31K 10-Q · filed 2018-05-14 | -$966.90K 10-Q · filed 2017-05-11 | -$6.51M derived: sum of 2 quarters · filed 2018-05-14 | -$8.54M derived: sum of 3 quarters · filed 2018-05-14 | -$13.15M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$8.05M derived: sum of 2 quarters · filed 2018-04-02 | -$12.66M derived: sum of 3 quarters · filed 2018-04-02 | -$13.73M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | -$2.03M 10-Q · filed 2017-11-14 | -$6.63M derived: sum of 2 quarters · filed 2017-11-14 | -$7.71M 10-Q · filed 2017-11-14 | -$15.69M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | -$4.61M 10-Q · filed 2017-08-14 | -$5.68M 10-Q · filed 2017-08-14 | -$13.66M derived: sum of 3 quarters · filed 2017-08-14 | -$14.52M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$1.07M 10-Q · filed 2017-05-11 | -$9.05M derived: sum of 2 quarters · filed 2017-05-11 | -$9.92M derived: sum of 3 quarters · filed 2017-05-11 | -$8.53M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | -$7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$8.85M derived: sum of 2 quarters · filed 2017-03-31 | -$7.46M derived: sum of 3 quarters · filed 2017-03-31 | -$20.10M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | -$863.04K 10-Q · filed 2016-11-14 | -$8.19M 10-Q · filed 2015-11-16 | $523.50K derived: sum of 2 quarters · filed 2016-11-14 | -$12.12M 10-Q · filed 2016-11-14 | -$19.44M 10-Q · filed 2015-11-16 | -$25.03M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $1.39M 10-Q · filed 2016-08-11 | -$3.77M 10-Q · filed 2015-08-14 | -$6.10M 10-Q · filed 2016-08-11 | -$11.25M 10-Q · filed 2015-08-14 | -$24.16M derived: sum of 3 quarters · filed 2016-08-11 | -$30.46M derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | -$3.63M 10-Q · filed 2016-05-16 | -$7.49M 10-Q · filed 2015-05-11 | -$25.55M derived: sum of 2 quarters · filed 2016-05-16 | -$31.84M derived: sum of 3 quarters · filed 2016-05-16 | -$40.33M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$21.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$28.21M derived: sum of 2 quarters · filed 2016-03-30 | -$36.70M derived: sum of 3 quarters · filed 2016-03-30 | -$40.20M 10-K · filed 2016-03-30 | -$26.69M 10-K · filed 2015-03-30 | |||
| 2014-09-30 | -$6.29M 10-Q · filed 2015-12-28 | -$14.78M derived: sum of 2 quarters · filed 2015-12-28 | -$18.29M 10-Q · filed 2015-12-28 | -$28.20M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-06-30 | -$8.49M 10-Q · filed 2015-08-14 | -$11.99M 10-Q · filed 2015-08-14 | -$21.91M derived: sum of 3 quarters · filed 2015-12-28 | -$23.33M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-03-31 | -$3.51M 10-Q · filed 2015-12-28 | -$13.42M derived: sum of 2 quarters · filed 2015-12-28 | -$14.84M derived: sum of 3 quarters · filed 2015-12-28 | -$17.09M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2013-12-31 | -$9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | -$11.33M derived: sum of 2 quarters · filed 2015-12-28 | -$13.58M derived: sum of 3 quarters · filed 2015-12-28 | -$15.57M 10-K · filed 2015-12-28 | ||||
| 2013-09-30 | -$1.42M 10-Q · filed 2014-11-14 | -$3.67M derived: sum of 2 quarters · filed 2014-11-14 | -$5.66M 10-Q · filed 2014-11-14 | |||||
| 2013-06-30 | -$2.24M 10-Q · filed 2014-08-14 | -$4.24M 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | -$1.99M 10-Q · filed 2014-05-15 | |||||||
| 2012-12-31 | $5.89M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |